Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.51B |
| 2 |
Microsoft
MSFT
|
+$1.13B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.04B |
| 4 |
American Express
AXP
|
+$714M |
| 5 |
HCA Healthcare
HCA
|
+$675M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$6.87B |
| 2 |
Wells Fargo
WFC
|
+$6.1B |
| 3 |
Becton Dickinson
BDX
|
+$3.96B |
| 4 |
Tesla
TSLA
|
+$3.74B |
| 5 |
3M
MMM
|
+$1.33B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.87% |
| 2 | Financials | 15.4% |
| 3 | Healthcare | 15.27% |
| 4 | Consumer Discretionary | 11.41% |
| 5 | Communication Services | 10.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Gray Television
GTN
$552M
| $43.6M | ﹤0.01% |
2,489,033
-1,172,964
| -32% | -$19.2M |
|
|
TFCF
1327
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| $43.3M | ﹤0.01% |
945,693
+659,503
| +230% | +$29.9M |
|
1328
Halozyme
HALO
$12.2B
| $43.3M | ﹤0.01% |
2,381,296
-91,885
| -4% | -$1.61M |
|
|
PTLA
1329
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $43.3M | ﹤0.01% |
1,624,486
-376,931
| -19% | -$12.3M |
|
1330
CTS Corp
CTS
$1.89B
| $43.2M | ﹤0.01% |
1,260,738
-21,987
| -2% | -$793K |
|
1331
Bio-Rad Laboratories Class A
BIO
$9.42B
| $43M | ﹤0.01% |
137,322
-471
| -0.3% | -$146K |
|
|
PGRE
1332
DELISTED
Paramount Group
PGRE
| $42.9M | ﹤0.01% |
2,841,000
-35,000
| -1% | -$543K |
|
1333
Armstrong World Industries
AWI
$7.84B
| $42.9M | ﹤0.01% |
615,913
-53,757
| -8% | -$3.71M |
|
1334
iShares US Real Estate ETF
IYR
$4.65B
| $42.7M | ﹤0.01% |
533,602
-20,841
| -4% | -$1.7M |
|
1335
Duluth Holdings
DLTH
$159M
| $42.6M | ﹤0.01% |
1,354,463
-343,951
| -20% | -$9.4M |
|
1336
BWX Technologies
BWXT
$15.6B
| $42.5M | ﹤0.01% |
678,862
+4,520
| +0.7% | +$286K |
|
|
XNET
1337
Xunlei
XNET
$326M
| $42.4M | ﹤0.01% |
5,846,778
-245,966
| -4% | -$2.45M |
|
|
JBGS
1338
JBG SMITH
JBGS
$708M
| $42.4M | ﹤0.01% |
1,151,791
-1,180,589
| -51% | -$43.5M |
|
|
ELP
1339
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $42.4M | ﹤0.01% |
20,115,578
+1,478,150
| +8% | +$3.13M |
|
|
EGL
1340
DELISTED
Engility Holdings, Inc.
EGL
| $42.4M | ﹤0.01% |
1,177,468
-1,962,939
| -63% | -$67.6M |
|
1341
Brown-Forman Class B
BF.B
$13.1B
| $42.1M | ﹤0.01% |
833,698
+10,027
| +1% | +$521K |
|
|
BHBK
1342
DELISTED
Blue Hills Bancorp, Inc.
BHBK
| $42.1M | ﹤0.01% |
1,748,543
-622,505
| -26% | -$14.1M |
|
|
OSG
1343
Octave Specialty Group
OSG
$222M
| $42.1M | ﹤0.01% |
2,060,260
| – | – |
|
1344
Aclaris Therapeutics
ACRS
$825M
| $42M | ﹤0.01% |
2,895,917
-459,868
| -14% | -$7.88M |
|
1345
Axogen
AXGN
$2.5B
| $42M | ﹤0.01% |
1,138,404
+9,919
| +0.9% | +$433K |
|
1346
Sea Limited
SE
$69.5B
| $41.8M | ﹤0.01% |
+3,024,100
| New | +$43.6M |
|
1347
Luxfer Holdings
LXFR
$458M
| $41.8M | ﹤0.01% |
1,798,529
-401,028
| -18% | -$8.25M |
|
1348
AC Immune
ACIU
$240M
| $41.7M | ﹤0.01% |
5,209,673
+1,166,524
| +29% | +$11.7M |
|
1349
iShares Russell Mid-Cap ETF
IWR
$57.4B
| $41.6M | ﹤0.01% |
755,136
-12,348
| -2% | -$677K |
|
1350
Fox Factory Holding Corp
FOXF
$886M
| $41.5M | ﹤0.01% |
592,868
-218,532
| -27% | -$13.4M |
|
Similar funds
Fidelity Investments's Q3 2018 Portfolio in Review
As of Q3 2018, Fidelity Investments held 3,957 positions worth $889B, up 2.3% from $869B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Fidelity Investments withdrew a net $33.9B in Q3 2018, closing 54 positions and reducing 1,318 holdings. Its most notable exit was Williams Partners L.P., an estimated $511M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Fidelity Investments opened a new position in Rubius Therapeutics, Inc worth $141M.
- Fidelity Investments's largest Q3 2018 buy was Rubius Therapeutics, Inc: 6,226,764 shares worth $141M.
- Fidelity Investments added most to Apple in Q3 2018, an estimated $1.51B increase.
- Fidelity Investments's biggest Q3 2018 reduction was Amgen, cutting an estimated $6.87B.
- Fidelity Investments fully exited Williams Partners L.P. in Q3 2018, selling an estimated $511M.
- Fidelity Investments's ten largest holdings make up 22% of its $889B portfolio in Q3 2018.
- Fidelity Investments opened 1,284 new positions and closed 54 in Q3 2018.
- Fidelity Investments's portfolio value rose 2.3% quarter-over-quarter to $889B.
Based on Fidelity Investments's 13F filing for Q3 2018, filed 9 Nov 2018.